Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Seattle Genetics Inc (SGEN)’

Stock Market Traders Trading

Hedge Fund and Insider Trading News: Jim Simons, Nelson Peltz, Baker Bros. Advisors, Facebook Inc (FB), Covenant Transportation Group, Inc. (CVTI), and More

How Jim Simons Built the World’s Most Lucrative Black Box (Bloomberg) Anyone looking to learn how a quant fund conquered the financial world should......(read more)
background, modern, room,

Hedge Fund and Insider Trading News: Dan Loeb, Michael Platt, Rapid7 Inc (RPD), Seattle Genetics, Inc. (SGEN), PHI Group, Inc. (PHIL), and More

‘There’s Finally an Alternative to Equities,’ Says Billionaire Fund Manager (MarketWatch) The stock market’s main gauges will rack up weekly gains......(read more)
Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More

Einhorn Says Greenlight Underperformance Is Worst Since 2000 (Bloomberg) Hedge fund manager David Einhorn said a shift in favor of value stocks may soon......(read more)

13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)

Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......(read more)
Felix Baker - Baker Bros.

13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,

These 5 NASDAQ Stocks Just Hit Their 52-Week Highs

Equities have seen a pullback amid uncertainty regarding the Federal Reserve’s plans to hike the interest rates. More specifically, the NASDAQ......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Delving Into Seattle Genetics, Inc. (SGEN)’s Upcoming Readout

Seattle Genetics, Inc. (NASDAQ:SGEN) just reported second quarter financials, and the company is up nearly 10% on the data. Alongside the numbers, however......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors

While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......(read more)
Felix Baker - Baker Bros.

Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More

Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
TRIAN PARTNERS

Billionaire Christian Leone Boosts Stake in This TV Station Operator, Nelson Peltz Lifts Stake in Struggling Pentair plc. (PNR), Plus 2 Other Moves

Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should......(read more)

The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1

Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since......(read more)
Felix Baker - Baker Bros.

Top 5 Healthcare Bets of World-Class Baker Bros. Advisors

Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
Barry Rosenstein JANA PARTNERS

Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company

You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)
Cheniere LNG Tanker Shipping Ship Liquid Natural Gas Vessel Fuel Carrier

Strong Insider Selling Activity Detected: Cheniere Energy Inc. (LNG) and Others

Generally, insider trading activity represents an important tool in the process of fundamental security analysis, as it can offer some insights on how......(read more)
Felix Baker - Baker Bros.

Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another

Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In......(read more)
Felix Baker - Baker Bros.

Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks

Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......(read more)
Felix Baker - Baker Bros.

Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock

Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,......(read more)
Felix Baker - Baker Bros.

Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves

Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued......(read more)
Felix Baker - Baker Bros.

Felix Baker’s Baker Bros. Advisors Raises Positions In These Stocks

In several new filings with the Securities and Exchange Commission, Julian and Felix Bakers‘ healthcare-focused fund Baker Bros. Advisors reported......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Baker Bros. Advisors Ups Stake in Seattle Genetics Inc. (SGEN)

Baker Bros. Advisors, managed by Julian Baker and Felix Baker, have disclosed raising its stake in Seattle Genetics Inc. (NASDAQ:SGEN). In a new filing......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)

Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and......(read more)

Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......(read more)

Five Hedge Fund Moves in Healthcare Sector From This Week

The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow. According to Morningstar......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Baker Bros. Strengthens Position in Seattle Genetics, Inc. (SGEN)

Julian Baker and Felix Baker have increased their exposure to Seattle Genetics, Inc. (NASDAQ:SGEN) even higher. In a newly amended filing with the SEC......(read more)
Bill Miller

Hedge Fund News: Bill Miller, Richard Perry & Alphonse Fletcher

Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary......(read more)
MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors

In pharmacology, we don’t only have to consider the actions of the drug on the body. It is also important to understand the way the body processes......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Pfizer Inc. (PFE): Is Seattle Genetics (SGEN) an Acquisition Target?

In late August, Amgen agreed to buy Onyx Pharmaceuticals in one of the worst-kept M&A secrets of the year. Amgen paid 50% more than Onyx’s pre......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector

With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)

In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......(read more)
Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?

In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......(read more)
Amgen, Inc. (NASDAQ:AMGN)

The Amgen, Inc. (AMGN)-Onyx Pharmaceuticals, Inc. (ONXX) Deal Should Make All Biotech Investors Happy

As I’m sure you’ve probably heard by now, Amgen, Inc. (NASDAQ:AMGN) agreed to purchase Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) for $125......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......(read more)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)

Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze......(read more)
Medivation Inc (NASDAQ:MDVN)

What Hedge Funds Think About Medivation Inc (MDVN)

Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......(read more)
Illumina, Inc. (NASDAQ:ILMN)

Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?

If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?

There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): This Company Has Potential to Grow

Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star......(read more)
Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), Onyx Pharmaceuticals, Inc. (ONXX), Seattle Genetics, Inc. (SGEN): Betting on Blockbusters

Global biotechnology industry revenue is expected to reach $262 billion this year showing growth of around 12.7% year over year. This industry has witnessed......(read more)
Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Celldex Therapeutics, Inc. (CLDX) On The Rise

There are many biotech stocks that target cancer, but what is good about Celldex Therapeutics, Inc. (NASDAQ:CLDX) is that it is targeting many therapeutic......(read more)

Immunomedics, Inc. (IMMU), ImmunoGen, Inc. (IMGN): Should You Invest in These Cancer Treatment Biotechs?

Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country. 1.7 million new......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Seattle Genetics, Inc. (SGEN): A Billion-Dollar Anticancer Technology in the Making

Anticancer drugs typically damage normal cells as well as cancer cells. Using a breakthrough technology, a midsize biotech company is developing a process......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD): Look Before You Leap With This Company

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a bio-pharmaceutical company that specializes in the innovation of small-molecule drugs that are used to......(read more)
Amarin Corporation plc (ADR) (NASDAQ:AMRN)

Amarin Corporation plc (ADR) (AMRN): Something Fishy? Or Business as Usual?

Mark your calendars Amarin Corporation plc (ADR) (NASDAQ:AMRN) investors. The biotech’s fish oil, Vascepa, will get its day in front of a Food and......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators

The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co. (NYSE:BMY) presented really promising updates for its PD-......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD) Soars On Hedge Fund Investment

One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are......(read more)

Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against Leukemia

As I noted 11 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)

Biogen Idec Inc. (BIIB), Pharmacyclics, Inc. (PCYC), Immunomedics, Inc. (IMMU), and Tackling Cancer, Non-Hodgkin Lymphoma’s Biggest Current & Upcoming Players

As I noted seven weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)

What Is This CEO Doing to Earn $450 Per Hour? – Geron Corporation (GERN)

The questions from analysts at the end of a company’s conference call typically fall in the softball category. There’s often a lot of backslapping......(read more)
Dendreon Corporation (NASDAQ:DNDN)

This FDA Approval Is Actually a Big Deal: Dendreon Corporation (DNDN)

As we’ve learned in recent years, getting an approval from the Food and Drug Administration is only half the battle. Successfully commercializing......(read more)